APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioconjugates Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bioconjugates Service Market Analysis and Forecast 2026-2032

22 January 2026214 pages

Choose your research edition.

Industry ResearchBioconjugates Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioconjugates Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Bioconjugates Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioconjugates Service Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioconjugates Service Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Bioconjugates Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bioconjugates Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bioconjugates Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bioconjugates Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bioconjugates Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bioconjugates Service include CellMosaic, AAT Bioquest, Creative Biolabs, Lonza, Bio-Synthesis, NJ Bio, Macrocyclics, KareBay and MuseChem, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bioconjugates Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bioconjugates Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Bioconjugates Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bioconjugates Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bioconjugates Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bioconjugates Service revenue, projected growth trends, production technology, application and end-user industry.

Bioconjugates Service Segment by Company

CellMosaic

AAT Bioquest

Creative Biolabs

Lonza

Bio-Synthesis

NJ Bio

Macrocyclics

KareBay

MuseChem

CheMatech

Recipharm

Nanocs

Vector Laboratories

Cell Signaling Technology

Thermo Fisher

WuXi Biologics

Celares

GTP Bioways

Antibody Solutions

BOC Sciences

Novasep

Bioconjugates Service Segment by Type

Covalent Conjugation Service

Non-Covalent Conjugation Service

Site-specific Conjugation Service

Bioconjugates Service Segment by Application

Therapeutic Drug Development

Diagnostic Probe Manufacturing

Basic Biological Research

Other

Bioconjugates Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugates Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioconjugates Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugates Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bioconjugates Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bioconjugates Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioconjugates Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bioconjugates Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Covalent Conjugation Service Major Player Table 3. Non-Covalent Conjugation Service Major Player Table 4. Site-specific Conjugation Service Major Player Table 5. Global Bioconjugates Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Therapeutic Drug Development Major Player Table 7. Diagnostic Probe Manufacturing Major Player Table 8. Basic Biological Research Major Player Table 9. Other Major Player Table 10. Bioconjugates Service Industry Trends Table 11. Bioconjugates Service Industry Drivers Table 12. Bioconjugates Service Industry Opportunities and Challenges Table 13. Bioconjugates Service Industry Restraints Table 14. Global Bioconjugates Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Bioconjugates Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Bioconjugates Service Market Share by Region (2021-2026) Table 17. Global Bioconjugates Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Bioconjugates Service Market Share by Region (2027-2032) Table 19. Global Bioconjugates Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Bioconjugates Service Revenue Market Share by Players (2021-2026) Table 21. Global Bioconjugates Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Bioconjugates Service Key Players Headquarters & Area Served Table 23. Global Bioconjugates Service Players, Product Type & Application Table 24. Global Bioconjugates Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Bioconjugates Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Bioconjugates Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Bioconjugates Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Bioconjugates Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Bioconjugates Service Revenue Market Share by Type (2021-2026) Table 31. Global Bioconjugates Service Revenue Market Share by Type (2027-2032) Table 32. Global Bioconjugates Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Bioconjugates Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Bioconjugates Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Bioconjugates Service Revenue Market Share by Application (2021-2026) Table 36. Global Bioconjugates Service Revenue Market Share by Application (2027-2032) Table 37. CellMosaic Company Information Table 38. CellMosaic Business Overview Table 39. CellMosaic Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. CellMosaic Bioconjugates Service Product Portfolio Table 41. CellMosaic Recent Development Table 42. AAT Bioquest Company Information Table 43. AAT Bioquest Business Overview Table 44. AAT Bioquest Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. AAT Bioquest Bioconjugates Service Product Portfolio Table 46. AAT Bioquest Recent Development Table 47. Creative Biolabs Company Information Table 48. Creative Biolabs Business Overview Table 49. Creative Biolabs Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Creative Biolabs Bioconjugates Service Product Portfolio Table 51. Creative Biolabs Recent Development Table 52. Lonza Company Information Table 53. Lonza Business Overview Table 54. Lonza Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Lonza Bioconjugates Service Product Portfolio Table 56. Lonza Recent Development Table 57. Bio-Synthesis Company Information Table 58. Bio-Synthesis Business Overview Table 59. Bio-Synthesis Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Bio-Synthesis Bioconjugates Service Product Portfolio Table 61. Bio-Synthesis Recent Development Table 62. NJ Bio Company Information Table 63. NJ Bio Business Overview Table 64. NJ Bio Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. NJ Bio Bioconjugates Service Product Portfolio Table 66. NJ Bio Recent Development Table 67. Macrocyclics Company Information Table 68. Macrocyclics Business Overview Table 69. Macrocyclics Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Macrocyclics Bioconjugates Service Product Portfolio Table 71. Macrocyclics Recent Development Table 72. KareBay Company Information Table 73. KareBay Business Overview Table 74. KareBay Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. KareBay Bioconjugates Service Product Portfolio Table 76. KareBay Recent Development Table 77. MuseChem Company Information Table 78. MuseChem Business Overview Table 79. MuseChem Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. MuseChem Bioconjugates Service Product Portfolio Table 81. MuseChem Recent Development Table 82. CheMatech Company Information Table 83. CheMatech Business Overview Table 84. CheMatech Bioconjugates Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. CheMatech Bioconjugates Service Product Portfolio Table 86. CheMatech Recent Development Table 87. Recipharm Company Information Table 88. Recipharm Business Overview Table 89. Recipharm Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Recipharm Bioconjugates Service Product Portfolio Table 91. Recipharm Recent Development Table 92. Nanocs Company Information Table 93. Nanocs Business Overview Table 94. Nanocs Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Nanocs Bioconjugates Service Product Portfolio Table 96. Nanocs Recent Development Table 97. Vector Laboratories Company Information Table 98. Vector Laboratories Business Overview Table 99. Vector Laboratories Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Vector Laboratories Bioconjugates Service Product Portfolio Table 101. Vector Laboratories Recent Development Table 102. Cell Signaling Technology Company Information Table 103. Cell Signaling Technology Business Overview Table 104. Cell Signaling Technology Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Cell Signaling Technology Bioconjugates Service Product Portfolio Table 106. Cell Signaling Technology Recent Development Table 107. Thermo Fisher Company Information Table 108. Thermo Fisher Business Overview Table 109. Thermo Fisher Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Thermo Fisher Bioconjugates Service Product Portfolio Table 111. Thermo Fisher Recent Development Table 112. WuXi Biologics Company Information Table 113. WuXi Biologics Business Overview Table 114. WuXi Biologics Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. WuXi Biologics Bioconjugates Service Product Portfolio Table 116. WuXi Biologics Recent Development Table 117. Celares Company Information Table 118. Celares Business Overview Table 119. Celares Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Celares Bioconjugates Service Product Portfolio Table 121. Celares Recent Development Table 122. GTP Bioways Company Information Table 123. GTP Bioways Business Overview Table 124. GTP Bioways Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. GTP Bioways Bioconjugates Service Product Portfolio Table 126. GTP Bioways Recent Development Table 127. Antibody Solutions Company Information Table 128. Antibody Solutions Business Overview Table 129. Antibody Solutions Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Antibody Solutions Bioconjugates Service Product Portfolio Table 131. Antibody Solutions Recent Development Table 132. BOC Sciences Company Information Table 133. BOC Sciences Business Overview Table 134. BOC Sciences Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. BOC Sciences Bioconjugates Service Product Portfolio Table 136. BOC Sciences Recent Development Table 137. Novasep Company Information Table 138. Novasep Business Overview Table 139. Novasep Bioconjugates Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Novasep Bioconjugates Service Product Portfolio Table 141. Novasep Recent Development Table 142. North America Bioconjugates Service Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Bioconjugates Service Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Bioconjugates Service Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Bioconjugates Service Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Bioconjugates Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. North America Bioconjugates Service Revenue by Country (2021-2026) & (US$ Million) Table 148. North America Bioconjugates Service Revenue by Country (US$ Million) & (2027-2032) Table 149. Europe Bioconjugates Service Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe Bioconjugates Service Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe Bioconjugates Service Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Bioconjugates Service Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Bioconjugates Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Bioconjugates Service Revenue by Country (2021-2026) & (US$ Million) Table 155. Europe Bioconjugates Service Revenue by Country (US$ Million) & (2027-2032) Table 156. China Bioconjugates Service Revenue by Type (2021-2026) & (US$ Million) Table 157. China Bioconjugates Service Revenue by Type (2027-2032) & (US$ Million) Table 158. China Bioconjugates Service Revenue by Application (2021-2026) & (US$ Million) Table 159. China Bioconjugates Service Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Bioconjugates Service Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia Bioconjugates Service Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia Bioconjugates Service Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Bioconjugates Service Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Bioconjugates Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Bioconjugates Service Revenue by Region (US$ Million) & (2021-2026) Table 166. Asia Bioconjugates Service Revenue by Region (US$ Million) & (2027-2032) Table 167. SAMEA Bioconjugates Service Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Bioconjugates Service Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Bioconjugates Service Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Bioconjugates Service Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Bioconjugates Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Bioconjugates Service Revenue by Country (2021-2026) & (US$ Million) Table 173. SAMEA Bioconjugates Service Revenue by Country (US$ Million) & (2027-2032) Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Bioconjugates Service Image Figure 2. Global Bioconjugates Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioconjugates Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Covalent Conjugation Service Image Figure 5. Non-Covalent Conjugation Service Image Figure 6. Site-specific Conjugation Service Image Figure 7. Global Bioconjugates Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Bioconjugates Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Therapeutic Drug Development Image Figure 10. Diagnostic Probe Manufacturing Image Figure 11. Basic Biological Research Image Figure 12. Other Image Figure 13. Global Bioconjugates Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Bioconjugates Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Bioconjugates Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Bioconjugates Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Bioconjugates Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Bioconjugates Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Bioconjugates Service Revenue Market Share by Type (2021-2032) Figure 21. Global Bioconjugates Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Bioconjugates Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Bioconjugates Service Revenue Market Share by Application (2021-2032) Figure 24. North America Bioconjugates Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Bioconjugates Service Revenue Share by Type (2021-2032) Figure 26. North America Bioconjugates Service Revenue Share by Application (2021-2032) Figure 27. North America Bioconjugates Service Revenue Share by Country (2021-2032) Figure 28. United States Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Bioconjugates Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Bioconjugates Service Revenue Share by Type (2021-2032) Figure 33. Europe Bioconjugates Service Revenue Share by Application (2021-2032) Figure 34. Europe Bioconjugates Service Revenue Share by Country (2021-2032) Figure 35. Germany Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Bioconjugates Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Bioconjugates Service Revenue Share by Type (2021-2032) Figure 45. China Bioconjugates Service Revenue Share by Application (2021-2032) Figure 46. Asia Bioconjugates Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Bioconjugates Service Revenue Share by Type (2021-2032) Figure 48. Asia Bioconjugates Service Revenue Share by Application (2021-2032) Figure 49. Asia Bioconjugates Service Revenue Share by Region (2021-2032) Figure 50. Japan Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Bioconjugates Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Bioconjugates Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Bioconjugates Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Bioconjugates Service Revenue Share by Country (2021-2032) Figure 60. Brazil Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Bioconjugates Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Covalent Conjugation Service
  • Non-Covalent Conjugation Service
  • Site-specific Conjugation Service
Applications
  • Therapeutic Drug Development
  • Diagnostic Probe Manufacturing
  • Basic Biological Research
  • Other
Companies covered
  • CellMosaic
  • AAT Bioquest
  • Creative Biolabs
  • Lonza
  • Bio-Synthesis
  • NJ Bio
  • Macrocyclics
  • KareBay
  • MuseChem
  • CheMatech
  • Recipharm
  • Nanocs
  • Vector Laboratories
  • Cell Signaling Technology
  • Thermo Fisher
  • WuXi Biologics
  • Celares
  • GTP Bioways
  • Antibody Solutions
  • BOC Sciences
  • Novasep

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bioconjugates Service Market by Type
  3. 1.2.1 Global Bioconjugates Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Covalent Conjugation Service
  5. 1.2.3 Non-Covalent Conjugation Service
  6. 1.2.4 Site-specific Conjugation Service
  7. 1.3 Bioconjugates Service Market by Application
  8. 1.3.1 Global Bioconjugates Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Therapeutic Drug Development
  10. 1.3.3 Diagnostic Probe Manufacturing
  11. 1.3.4 Basic Biological Research
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Bioconjugates Service Market Dynamics
  1. 2.1 Bioconjugates Service Industry Trends
  2. 2.2 Bioconjugates Service Industry Drivers
  3. 2.3 Bioconjugates Service Industry Opportunities and Challenges
  4. 2.4 Bioconjugates Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bioconjugates Service Market Perspective (2021-2032)
  2. 3.2 Global Bioconjugates Service Growth Trends by Region
  3. 3.2.1 Global Bioconjugates Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bioconjugates Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Bioconjugates Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bioconjugates Service Revenue by Players
  2. 4.1.1 Global Bioconjugates Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Bioconjugates Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bioconjugates Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bioconjugates Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bioconjugates Service Key Players Headquarters & Area Served
  7. 4.4 Global Bioconjugates Service Players, Product Type & Application
  8. 4.5 Global Bioconjugates Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bioconjugates Service Market CR5 and HHI
  11. 4.6.3 2025 Bioconjugates Service Tier 1, Tier 2, and Tier 3
5 Bioconjugates Service Market Size by Type
  1. 5.1 Global Bioconjugates Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bioconjugates Service Revenue by Type (2021-2032)
  3. 5.3 Global Bioconjugates Service Revenue Market Share by Type (2021-2032)
6 Bioconjugates Service Market Size by Application
  1. 6.1 Global Bioconjugates Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bioconjugates Service Revenue by Application (2021-2032)
  3. 6.3 Global Bioconjugates Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CellMosaic
  2. 7.1.1 CellMosaic Company Information
  3. 7.1.2 CellMosaic Business Overview
  4. 7.1.3 CellMosaic Bioconjugates Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CellMosaic Bioconjugates Service Product Portfolio
  6. 7.1.5 CellMosaic Recent Developments
  7. 7.2 AAT Bioquest
  8. 7.2.1 AAT Bioquest Company Information
  9. 7.2.2 AAT Bioquest Business Overview
  10. 7.2.3 AAT Bioquest Bioconjugates Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AAT Bioquest Bioconjugates Service Product Portfolio
  12. 7.2.5 AAT Bioquest Recent Developments
  13. 7.3 Creative Biolabs
  14. 7.3.1 Creative Biolabs Company Information
  15. 7.3.2 Creative Biolabs Business Overview
  16. 7.3.3 Creative Biolabs Bioconjugates Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Creative Biolabs Bioconjugates Service Product Portfolio
  18. 7.3.5 Creative Biolabs Recent Developments
  19. 7.4 Lonza
  20. 7.4.1 Lonza Company Information
  21. 7.4.2 Lonza Business Overview
  22. 7.4.3 Lonza Bioconjugates Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lonza Bioconjugates Service Product Portfolio
  24. 7.4.5 Lonza Recent Developments
  25. 7.5 Bio-Synthesis
  26. 7.5.1 Bio-Synthesis Company Information
  27. 7.5.2 Bio-Synthesis Business Overview
  28. 7.5.3 Bio-Synthesis Bioconjugates Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bio-Synthesis Bioconjugates Service Product Portfolio
  30. 7.5.5 Bio-Synthesis Recent Developments
  31. 7.6 NJ Bio
  32. 7.6.1 NJ Bio Company Information
  33. 7.6.2 NJ Bio Business Overview
  34. 7.6.3 NJ Bio Bioconjugates Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NJ Bio Bioconjugates Service Product Portfolio
  36. 7.6.5 NJ Bio Recent Developments
  37. 7.7 Macrocyclics
  38. 7.7.1 Macrocyclics Company Information
  39. 7.7.2 Macrocyclics Business Overview
  40. 7.7.3 Macrocyclics Bioconjugates Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Macrocyclics Bioconjugates Service Product Portfolio
  42. 7.7.5 Macrocyclics Recent Developments
  43. 7.8 KareBay
  44. 7.8.1 KareBay Company Information
  45. 7.8.2 KareBay Business Overview
  46. 7.8.3 KareBay Bioconjugates Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 KareBay Bioconjugates Service Product Portfolio
  48. 7.8.5 KareBay Recent Developments
  49. 7.9 MuseChem
  50. 7.9.1 MuseChem Company Information
  51. 7.9.2 MuseChem Business Overview
  52. 7.9.3 MuseChem Bioconjugates Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MuseChem Bioconjugates Service Product Portfolio
  54. 7.9.5 MuseChem Recent Developments
  55. 7.10 CheMatech
  56. 7.10.1 CheMatech Company Information
  57. 7.10.2 CheMatech Business Overview
  58. 7.10.3 CheMatech Bioconjugates Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CheMatech Bioconjugates Service Product Portfolio
  60. 7.10.5 CheMatech Recent Developments
  61. 7.11 Recipharm
  62. 7.11.1 Recipharm Company Information
  63. 7.11.2 Recipharm Business Overview
  64. 7.11.3 Recipharm Bioconjugates Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Recipharm Bioconjugates Service Product Portfolio
  66. 7.11.5 Recipharm Recent Developments
  67. 7.12 Nanocs
  68. 7.12.1 Nanocs Company Information
  69. 7.12.2 Nanocs Business Overview
  70. 7.12.3 Nanocs Bioconjugates Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Nanocs Bioconjugates Service Product Portfolio
  72. 7.12.5 Nanocs Recent Developments
  73. 7.13 Vector Laboratories
  74. 7.13.1 Vector Laboratories Company Information
  75. 7.13.2 Vector Laboratories Business Overview
  76. 7.13.3 Vector Laboratories Bioconjugates Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Vector Laboratories Bioconjugates Service Product Portfolio
  78. 7.13.5 Vector Laboratories Recent Developments
  79. 7.14 Cell Signaling Technology
  80. 7.14.1 Cell Signaling Technology Company Information
  81. 7.14.2 Cell Signaling Technology Business Overview
  82. 7.14.3 Cell Signaling Technology Bioconjugates Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cell Signaling Technology Bioconjugates Service Product Portfolio
  84. 7.14.5 Cell Signaling Technology Recent Developments
  85. 7.15 Thermo Fisher
  86. 7.15.1 Thermo Fisher Company Information
  87. 7.15.2 Thermo Fisher Business Overview
  88. 7.15.3 Thermo Fisher Bioconjugates Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Thermo Fisher Bioconjugates Service Product Portfolio
  90. 7.15.5 Thermo Fisher Recent Developments
  91. 7.16 WuXi Biologics
  92. 7.16.1 WuXi Biologics Company Information
  93. 7.16.2 WuXi Biologics Business Overview
  94. 7.16.3 WuXi Biologics Bioconjugates Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 WuXi Biologics Bioconjugates Service Product Portfolio
  96. 7.16.5 WuXi Biologics Recent Developments
  97. 7.17 Celares
  98. 7.17.1 Celares Company Information
  99. 7.17.2 Celares Business Overview
  100. 7.17.3 Celares Bioconjugates Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Celares Bioconjugates Service Product Portfolio
  102. 7.17.5 Celares Recent Developments
  103. 7.18 GTP Bioways
  104. 7.18.1 GTP Bioways Company Information
  105. 7.18.2 GTP Bioways Business Overview
  106. 7.18.3 GTP Bioways Bioconjugates Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 GTP Bioways Bioconjugates Service Product Portfolio
  108. 7.18.5 GTP Bioways Recent Developments
  109. 7.19 Antibody Solutions
  110. 7.19.1 Antibody Solutions Company Information
  111. 7.19.2 Antibody Solutions Business Overview
  112. 7.19.3 Antibody Solutions Bioconjugates Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Antibody Solutions Bioconjugates Service Product Portfolio
  114. 7.19.5 Antibody Solutions Recent Developments
  115. 7.20 BOC Sciences
  116. 7.20.1 BOC Sciences Company Information
  117. 7.20.2 BOC Sciences Business Overview
  118. 7.20.3 BOC Sciences Bioconjugates Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 BOC Sciences Bioconjugates Service Product Portfolio
  120. 7.20.5 BOC Sciences Recent Developments
  121. 7.21 Novasep
  122. 7.21.1 Novasep Company Information
  123. 7.21.2 Novasep Business Overview
  124. 7.21.3 Novasep Bioconjugates Service Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Novasep Bioconjugates Service Product Portfolio
  126. 7.21.5 Novasep Recent Developments
8 North America
  1. 8.1 North America Bioconjugates Service Revenue (2021-2032)
  2. 8.2 North America Bioconjugates Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Bioconjugates Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Bioconjugates Service Revenue by Type (2027-2032)
  5. 8.3 North America Bioconjugates Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Bioconjugates Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Bioconjugates Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Bioconjugates Service Revenue by Application (2027-2032)
  9. 8.5 North America Bioconjugates Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Bioconjugates Service Revenue by Country
  11. 8.6.1 North America Bioconjugates Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bioconjugates Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Bioconjugates Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Bioconjugates Service Revenue (2021-2032)
  2. 9.2 Europe Bioconjugates Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bioconjugates Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bioconjugates Service Revenue by Type (2027-2032)
  5. 9.3 Europe Bioconjugates Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bioconjugates Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bioconjugates Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bioconjugates Service Revenue by Application (2027-2032)
  9. 9.5 Europe Bioconjugates Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bioconjugates Service Revenue by Country
  11. 9.6.1 Europe Bioconjugates Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bioconjugates Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bioconjugates Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Bioconjugates Service Revenue (2021-2032)
  2. 10.2 China Bioconjugates Service Revenue by Type (2021-2032)
  3. 10.2.1 China Bioconjugates Service Revenue by Type (2021-2026)
  4. 10.2.2 China Bioconjugates Service Revenue by Type (2027-2032)
  5. 10.3 China Bioconjugates Service Revenue Share by Type (2021-2032)
  6. 10.4 China Bioconjugates Service Revenue by Application (2021-2032)
  7. 10.4.1 China Bioconjugates Service Revenue by Application (2021-2026)
  8. 10.4.2 China Bioconjugates Service Revenue by Application (2027-2032)
  9. 10.5 China Bioconjugates Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bioconjugates Service Revenue (2021-2032)
  2. 11.2 Asia Bioconjugates Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bioconjugates Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bioconjugates Service Revenue by Type (2027-2032)
  5. 11.3 Asia Bioconjugates Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bioconjugates Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bioconjugates Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bioconjugates Service Revenue by Application (2027-2032)
  9. 11.5 Asia Bioconjugates Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bioconjugates Service Revenue by Country
  11. 11.6.1 Asia Bioconjugates Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bioconjugates Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bioconjugates Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bioconjugates Service Revenue (2021-2032)
  2. 12.2 SAMEA Bioconjugates Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bioconjugates Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bioconjugates Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bioconjugates Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bioconjugates Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bioconjugates Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bioconjugates Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bioconjugates Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bioconjugates Service Revenue by Country
  11. 12.6.1 SAMEA Bioconjugates Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bioconjugates Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bioconjugates Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst